Pulmonary embolism cost-effectiveness of therapy: Difference between revisions
Ochuko Ajari (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pulmonary embolism}} | |||
'''Editor(s)-In-Chief:''' {{ATI}}, [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com]; | |||
{{ | ==Overview== | ||
When indicated, early discharge and outpatient treatment for pulmonary embolism (PE) is more cost effective than inpatient treatment.<ref name="pmid16162764">{{cite journal| author=Aujesky D, Smith KJ, Cornuz J, Roberts MS| title=Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. | journal=Chest | year= 2005 | volume= 128 | issue= 3 | pages= 1601-10 | pmid=16162764 | doi=10.1378/chest.128.3.1601 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16162764 }} </ref> The inpatient treatment with [[low molecular weight heparin]] has been reported to be more cost effective than that with [[unfractionated heparin]].<ref name="pmid16162764">{{cite journal| author=Aujesky D, Smith KJ, Cornuz J, Roberts MS| title=Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. | journal=Chest | year= 2005 | volume= 128 | issue= 3 | pages= 1601-10 | pmid=16162764 | doi=10.1378/chest.128.3.1601 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16162764 }} </ref> | |||
==References== | ==References== |
Revision as of 20:37, 11 July 2014
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism cost-effectiveness of therapy On the Web |
Pulmonary embolism cost-effectiveness of therapy in the news |
Directions to Hospitals Treating Pulmonary embolism cost-effectiveness of therapy |
Risk calculators and risk factors for Pulmonary embolism cost-effectiveness of therapy |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1];
Overview
When indicated, early discharge and outpatient treatment for pulmonary embolism (PE) is more cost effective than inpatient treatment.[1] The inpatient treatment with low molecular weight heparin has been reported to be more cost effective than that with unfractionated heparin.[1]
References
- ↑ 1.0 1.1 Aujesky D, Smith KJ, Cornuz J, Roberts MS (2005). "Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism". Chest. 128 (3): 1601–10. doi:10.1378/chest.128.3.1601. PMID 16162764.